A PTEN-Dependent Size Checkpoint in Human Cancer Cells
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
批准号:
7597077
负责人:
TODD A WALDMAN
金额:
$18.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-11 至 2011-03-31
关键词:
AffectAttenuatedBindingBiochemicalBiological ModelsCancer cell lineCell LineCell SizeCellsCharacteristicsDNA DamageDataDrosophila melanogasterG2 Checkpoint controlGTP-Binding ProteinsGene TargetingGenesGoalsGuanosine Triphosphate PhosphohydrolasesHCT116 CellsHouse miceHumanKnock-outKnowledgeLeadMalignant NeoplasmsMeasuresMutationNormal CellOncogenesOncogenicOrganismOxidative StressPIK3CA genePTEN genePathway interactionsPhenotypePhosphorylationPhosphotransferasesPoisonPropertyRadiationReportingResearch PersonnelSignal TransductionSignal Transduction PathwaySmall Interfering RNASomatic CellStimulusSystemTP53 Gene InactivationTP53 geneTSC2 geneTestingTransfectionTumor Suppressor GenesTumor Suppressor ProteinsVariantWorkcancer cellnovelprogramsresponsesmall hairpin RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Activation of PIP3 signaling by inactivating mutations in the PTEN tumor suppressor or activating mutations in the PIK3CA oncogene is found in a wide range of common human cancers. Though the biochemical details of PIP3 signal transduction are rapidly emerging, the phenotypic consequences of PIP3 pathway activation in human cancer cells remain less well defined. As such, the long-term goal of this project is to define the effects of PIP3 activation in human cancer cells. In our initial preliminary studies, we employed human somatic cell gene targeting to create isogenic sets of PTEN+/+ and PTEN-/- human cancer cell lines. Using these and related model systems, we found that PTEN controls a novel radiation-induced size checkpoint in human cells that is distinct and genetically separable from the radiation-induced, p53-dependent G1 and G2 checkpoints. To our knowledge, the existence of such a DNA damage-inducible size arrest has neither been postulated or demonstrated in any organism. Since the initial submission of this application we have employed human somatic cell gene targeting to create an isogenic set of PIK3CA gene targeted human cancer cells, and also created NIH3T3 cell lines that express wild-type, oncogenic, or inactive forms of PIK3CA. Using these systems we have obtained preliminary data suggesting that, like PTEN, the PIK3CA oncogene may be able to regulate size checkpoint function as well. In this application we propose three related specific aims to further pursue and extend these observations. Aim #1 - Identify additional inducers of the PTEN-dependent size checkpoint. Aim #2 - Demonstrate the presence of the PTEN-dependent size checkpoint in untransformed human cells. Aim #3 - Characterize crosstalk between the radiation-induced, p53-dependent G1/G2 checkpoints and the radiation-induced, PTEN-dependent cell size checkpoint. Pursuit of these aims will enable us to further characterize the properties and mechanism(s) of a tumor suppressor gene-regulated, radiation-induced cell size checkpoint.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
-
批准号:8501829
-
项目类别:
-
资助金额:$32.23万
-
财政年份:2013
-
负责人:TODD A WALDMAN
-
依托单位:
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
-
批准号:8819107
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2013
-
负责人:TODD A WALDMAN
-
依托单位:
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
-
批准号:8633441
-
项目类别:
-
资助金额:$31.3万
-
财政年份:2013
-
负责人:TODD A WALDMAN
-
依托单位:
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
-
批准号:9008028
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2013
-
负责人:TODD A WALDMAN
-
依托单位:
Development and Application of Endogenous Epitope Tagging Technology in Human Cel
-
批准号:7777680
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2010
-
负责人:TODD A WALDMAN
-
依托单位:
Development and Application of Endogenous Epitope Tagging Technology in Human Cel
-
批准号:8044714
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2010
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
-
批准号:7417921
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
-
批准号:7685028
-
项目类别:
-
资助金额:$6.06万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
-
批准号:7105903
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-dependent cell size checkpoint in human cells
-
批准号:8690786
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-dependent cell size checkpoint in human cells
-
批准号:8840893
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-dependent cell size checkpoint in human cells
-
批准号:8578465
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
-
批准号:7795200
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
-
批准号:7232030
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2006
-
负责人:TODD A WALDMAN
-
依托单位:
Isogenic Cell-Based Screen:Cancer-Targeting Catenin(RMI)
-
批准号:7407180
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2005
-
负责人:TODD A WALDMAN
-
依托单位:
Isogenic Cell-Based Screen:Cancer-Targeting Catenin(RMI)
-
批准号:7022520
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2005
-
负责人:TODD A WALDMAN
-
依托单位:
Cell-Based Screens for Cancer:Targeting PTEN (RMI)
-
批准号:6880221
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2004
-
负责人:TODD A WALDMAN
-
依托单位:
Genetic Analysis of Beta-Catenin Function in Human CA
-
批准号:6830781
-
项目类别:
-
资助金额:$27.49万
-
财政年份:2003
-
负责人:TODD A WALDMAN
-
依托单位:
Genetic Analysis of Beta-Catenin Function in Human CA
-
批准号:6576709
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2003
-
负责人:TODD A WALDMAN
-
依托单位:
Genetic Analysis of Beta-Catenin Function in Human CA
-
批准号:7154043
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2003
-
负责人:TODD A WALDMAN
-
依托单位:
海外基金